Intra-Arterial Thrombolytic Therapy Is Not a Therapeutic Option for Filler-Related Central Retinal Artery Occlusion

Abstract

Cosmetic facial filler-related central retinal artery occlusion (CRAO) is a devastating complication of facial hyaluronic acid (HA) injection and can be managed by intra-arterial thrombolytic therapy (IATT). The authors report on a 20-year-old woman who developed unilateral CRAO due to facial HA injection and who, despite prompt IATT, lost vision. A review of the related literature found 14 other female patients who developed cosmetic facial filler-related CRAO and accepted IATT management. In no case was vision loss clinically improved. IATT is not an effective preventive treatment of dermal filler-associated CRAO. The authors suggest careful preprocedural patient selection to prevent this complication.

Keywords

hyaluronic acid - dermal filler - central retinal artery occlusion - hyaluronidase - intra-arterial thrombolytic therapy

• References

• 1 Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg 2015; 41 (10) 1097-1117
• 2 Park SJ, Woo SJ, Park KH. , et al. Partial recovery after intraarterial pharmacomechanical thrombolysis in ophthalmic artery occlusion following nasal autologous fat injection. J Vasc Interv Radiol 2011; 22 (02) 251-254
• 3 Park SW, Woo SJ, Park KH, Huh JW, Jung C, Kwon OK. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am J Ophthalmol 2012; 154 (04) 653-662.e1
• 4 Qi X, Zhou J, Ma L, Qin J. Analysis of artery occlusion caused by facial autologous fat injections. Digit Med 2015; 1: 39-42
• 5 Oh BL, Jung C, Park KH, Hong YJ, Woo SJ. Therapeutic intra-arterial hyaluronidase infusion for ophthalmic artery occlusion following cosmetic facial filler (hyaluronic acid) injection. Neuroophthalmology 2014; 38 (01) 39-43
• 6 Park KH, Kim YK, Woo SJ. , et al; Korean Retina Society. Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections: a national survey by the Korean Retina Society. JAMA Ophthalmol 2014; 132 (06) 714-723
• 7 Kim YK, Jung C, Woo SJ, Park KH. Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery occlusion. J Korean Med Sci 2015; 30 (12) 1847-1855
• 8 Kim DW, Yoon ES, Ji YH, Park SH, Lee BI, Dhong ES. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthet Surg 2011; 64 (12) 1590-1595
• 9 Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg 2013; 15 (03) 226-231
• 10 DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J 2014; 34 (04) 584-600
• 11 Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997; 124 (05) 641-647
• 12 Li X, Du L, Lu JJ. A novel hypothesis of visual loss secondary to cosmetic facial filler injection. Ann Plast Surg 2015; 75 (03) 258-260
• 13 Ahn SJ, Kim JM, Hong JH. , et al. Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion. Invest Ophthalmol Vis Sci 2013; 54 (12) 7746-7755
• 14 Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011; 42 (06) 1775-1777
• 15 Jeansson M, Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006; 290 (01) F111-F116
• 16 Kwon DY, Park MH, Koh SB. , et al. Multiple arterial embolism after illicit intranasal injection of collagenous material. Dermatol Surg 2010; 36 (07) 1196-1199